We are live on
!
Find out more
BCB
Brian C. Broderick Portfolio holdings
AUM
$542M
1-Year Est. Return
20.28%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$376M
AUM Growth
+$29M
(+8.4%)
Cap. Flow
+$3.41M
Cap. Flow
% of AUM
0.91%
Top 10 Holdings %
Top 10 Hldgs %
37.04%
Holding
81
New
2
Increased
22
Reduced
37
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.02M |
| 2 |
Nike
NKE
|
+$960K |
| 3 |
TJX Companies
TJX
|
+$637K |
| 4 |
Becton Dickinson
BDX
|
+$591K |
| 5 |
UnitedHealth
UNH
|
+$413K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$1.29M |
| 2 |
Intel
INTC
|
+$841K |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$619K |
| 4 |
Apple
AAPL
|
+$535K |
| 5 |
Novartis
NVS
|
+$434K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.44% |
| 2 | Technology | 20.47% |
| 3 | Industrials | 12.94% |
| 4 | Financials | 8.08% |
| 5 | Consumer Discretionary | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Cigna
CI
$75.1B
| $485K | 0.13% |
2,048
-100
| -5% | -$25K |
|
52
GE Aerospace
GE
$354B
| $368K | 0.1% |
5,492
-301
| -5% | -$20.1K |
|
|
NVO
53
Novo Nordisk
NVO
$219B
| $358K | 0.1% |
8,550
-100
| -1% | -$3.88K |
|
54
Annovis Bio
ANVS
$71.9M
| $342K | 0.09% |
+4,000
| New | +$185K |
|
55
CSX Corp
CSX
$93.1B
| $327K | 0.09% |
10,200
| – | – |
|
56
Deere & Co
DE
$158B
| $324K | 0.09% |
920
-50
| -5% | -$18.3K |
|
57
Denali Therapeutics
DNLI
$3.63B
| $314K | 0.08% |
4,000
| – | – |
|
58
Eli Lilly
LLY
$1.02T
| $312K | 0.08% |
1,357
| – | – |
|
59
Baxter International
BAX
$11.4B
| $298K | 0.08% |
3,700
-100
| -3% | -$8.39K |
|
60
Pfizer
PFE
$141B
| $280K | 0.07% |
7,154
| – | – |
|
61
NextEra Energy
NEE
$184B
| $279K | 0.07% |
3,800
| – | – |
|
62
IBM
IBM
$200B
| $263K | 0.07% |
1,880
-130
| -6% | -$17.8K |
|
63
McDonald's
MCD
$190B
| $255K | 0.07% |
1,100
| – | – |
|
64
ConocoPhillips
COP
$141B
| $249K | 0.07% |
4,084
| – | – |
|
65
General Mills
GIS
$20.1B
| $244K | 0.06% |
4,000
| – | – |
|
66
Dow Inc
DOW
$21.9B
| $242K | 0.06% |
3,822
| – | – |
|
67
Walmart Inc
WMT
$893B
| $219K | 0.06% |
4,650
| – | – |
|
68
International Flavors & Fragrances
IFF
$19.7B
| $215K | 0.06% |
1,438
| – | – |
|
69
Ingersoll Rand
IR
$31.4B
| $214K | 0.06% |
4,385
| – | – |
|
70
Cyclerion Therapeutics
CYCN
$15.8M
| $126K | 0.03% |
1,609
| – | – |
|
71
Hartford Financial Services
HIG
$38.5B
| – | – |
-3,300
| Closed | -$220K |
|
Similar funds
MAM
GPWA
WCA
ISB
CIAM
FMC
HCM
FSA
Brian C. Broderick's Q2 2021 Portfolio in Review
As of Q2 2021, Brian C. Broderick held 81 positions worth $376M, up 8.4% from $347M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Trading was light in Q2 2021: portfolio turnover was 3.7%. Brian C. Broderick opened 2 new positions and exited 1, leaving the 81-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Industrials.
- Brian C. Broderick's largest Q2 2021 buy was Annovis Bio: 4,000 shares worth $342K.
- Brian C. Broderick added most to Honeywell in Q2 2021, an estimated $1.02M increase.
- Brian C. Broderick's biggest Q2 2021 reduction was 3M, cutting an estimated $1.29M.
- Brian C. Broderick fully exited Hartford Financial Services in Q2 2021, selling an estimated $220K.
- Brian C. Broderick's ten largest holdings make up 37% of its $376M portfolio in Q2 2021.
- Brian C. Broderick opened 2 new positions and closed 1 in Q2 2021.
- Brian C. Broderick's portfolio value rose 8.4% quarter-over-quarter to $376M.
Based on Brian C. Broderick's 13F filing for Q2 2021, filed 9 Aug 2021.